Physician profile
Suzanne C Abraham
NPI 1982655957
$3,519.13
in general payments reported to CMS, 2019-2025
25 companies · $439 in 2025
The $439 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $433 · 2021: $225 · 2022: $1,432 · 2023: $266 · 2024: $544 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,249.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impactortho, INC. | $1,230.60 | 2022 | |
| Organogenesis INC. | $430.42 | 2019-2025 | Apligraf, Puraply, Puraply Am |
| Stryker Corporation | $326.98 | 2020-2025 | Allowrap, Citrefix, Allograft |
| Orthofix Medical, INC. | $237.56 | 2019-2025 | Physio-Stim |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $181.27 | 2019-2024 | Jublia |
| Abbvie INC. | $127.64 | 2021-2025 | |
| Smith+Nephew, INC. | $126.56 | 2019-2021 | |
| Nevro Corp. | $116.43 | 2024 | Senza |
| Djo, LLC | $106.66 | 2020-2025 | Cmf |
| Paratek Pharmaceuticals, INC. | $89.50 | 2023-2025 | Nuzyra |
| Depuy Synthes Sales INC. | $88.19 | 2019-2023 | Dynaforce, Na, Fibulink |
| Wright Medical Technology, INC. | $67.97 | 2019 | |
| Allergan, INC. | $66.96 | 2020 | |
| Surgenex LLC | $61.30 | 2025 | Renograft, Surgraft, Ardeograft |
| Convatec INC. | $52.46 | 2021-2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $27.30 | 2024 | Celleraterx |
| Hartmann USA, INC. | $26.32 | 2024 | Zetuvit Plus 10x10 P10 |
| Biom'Up France Sas | $25.74 | 2021 | |
| Solventum Corporation | $22.47 | 2024 | Activ.A.C. |
| Ibsa Pharma INC. | $20.83 | 2024 | Flector, Tirosint, Licart |
| Fusion Orthopedics USA, LLC | $20.79 | 2025 | |
| Goode Surgical INC | $20.02 | 2020 | |
| Forthright Medical - Az, LLC | $18.90 | 2024 | |
| Abbott Laboratories | $14.30 | 2020 | |
| Trice Medical, INC. | $11.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.